Variant report
Variant | nsv998682 |
---|---|
Chromosome Location | chr3:42360106-42372639 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOXA2 | chr3:42370653-42370857 | HepG2 | liver: | n/a | n/a |
2 | GATA3 | chr3:42370680-42370779 | SH-SY5Y | brain: | n/a | n/a |
3 | JUND | chr3:42370172-42370290 | HepG2 | liver: | n/a | n/a |
4 | MAFK | chr3:42371536-42371579 | HepG2 | liver: | n/a | n/a |
5 | MAFK | chr3:42371048-42371198 | HepG2 | liver: | n/a | n/a |
6 | MYC | chr3:42362964-42363036 | MCF-7 | breast: | n/a | n/a |
7 | MYC | chr3:42371887-42372084 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr3:42363001-42363005 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr3:42362951-42363023 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr3:42363010-42363064 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr3:42362916-42362946 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr3:42368249-42368403 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr3:42367772-42367972 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr3:42360560-42360615 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:42355817..42358731-chr3:42372025..42373776,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SALL4P6 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552881238 | chr3:42360573-42360574 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs7634057 | chr3:42360590-42360591 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs578148570 | chr3:42360631-42360632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543127716 | chr3:42360645-42360646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562234529 | chr3:42360731-42360732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375374071 | chr3:42360749-42360750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141526572 | chr3:42360803-42360804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528872975 | chr3:42360834-42360835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548958180 | chr3:42360864-42360865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs474470 | chr3:42360871-42360872 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs142877475 | chr3:42360935-42360936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550308703 | chr3:42360944-42360945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571334100 | chr3:42361020-42361021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186825608 | chr3:42361042-42361043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549999529 | chr3:42361056-42361057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151051418 | chr3:42361076-42361077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191554348 | chr3:42361132-42361133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555311207 | chr3:42361199-42361200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs678574 | chr3:42362817-42362818 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs550255404 | chr3:42362860-42362861 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559919175 | chr3:42362866-42362867 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528538261 | chr3:42362885-42362886 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551617352 | chr3:42362919-42362920 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192858094 | chr3:42362938-42362939 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs677695 | chr3:42362969-42362970 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184823215 | chr3:42363001-42363002 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114198767 | chr3:42363058-42363059 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79210575 | chr3:42363098-42363099 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76302012 | chr3:42363099-42363100 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538714580 | chr3:42363102-42363103 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74405898 | chr3:42363108-42363109 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17081666 | chr3:42363126-42363127 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs189193913 | chr3:42363186-42363187 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574346950 | chr3:42363192-42363193 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540159970 | chr3:42363243-42363244 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191374561 | chr3:42363277-42363278 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576991669 | chr3:42363292-42363293 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545481002 | chr3:42363316-42363317 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147416888 | chr3:42363330-42363331 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375141795 | chr3:42363344-42363345 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17223780 | chr3:42363369-42363370 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs55881614 | chr3:42363370-42363371 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs550945784 | chr3:42363375-42363376 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561287283 | chr3:42363380-42363381 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs530380575 | chr3:42363408-42363409 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563366207 | chr3:42363424-42363425 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547349709 | chr3:42363445-42363446 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567052365 | chr3:42363484-42363485 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs533648456 | chr3:42363499-42363500 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80089405 | chr3:42363540-42363541 | ZNF genes & repeats Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Wilms tumour | 17204608 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 21693616 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 20409316 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:42360600-42361200 | Enhancers | Brain Germinal Matrix | brain |
2 | chr3:42362800-42363600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr3:42362800-42363600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:42363200-42366600 | Weak transcription | Right Atrium | heart |
5 | chr3:42369400-42369600 | Bivalent Enhancer | HSMMtube | muscle |
6 | chr3:42369400-42369800 | Enhancers | Colon Smooth Muscle | Colon |